Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 42,431 shares at $8.27 ($351K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($351k) by SVP, Business Development — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |
| VNDA | SELL | 2020-03-04 | $363K | — | Filing → |